New anti-cancer drug discovery alliance between GlaxoSmithKline, the Wellcome Trust and The Institute of Cancer Research, focused on B-RAF inhibitors, builds on partnership between Astex, the Wellcome Trust, the Institute of Cancer Research and Cancer Res

New anti-cancer drug discovery alliance between GlaxoSmithKline, the Wellcome Trust and The Institute of Cancer Research, focused on B-RAF inhibitors, builds on partnership between Astex, the Wellcome Trust, the Institute of Cancer Research and Cancer Res

SuperGen Announces Attainment of Milestone from the MGI PHARMA / Cilag GmbH, a Johnson & Johnson Company, Licensing for Dacogen(TM) (Decitabine) for Injection

SuperGen Announces Attainment of Milestone from the MGI PHARMA / Cilag GmbH, a Johnson & Johnson Company, Licensing for Dacogen(TM) (Decitabine) for Injection